Long-term treatment with CellCept (mycophenolic acid) or Cytoxan (cyclophosphamide) can significantly reduce skin thickening in patients with systemic sclerosis (SSc),…
Articles by Alice Melão, MSc
Results from a Phase 2 trial assessing the safety and efficacy of anabasum (formerly known as Resunab or JBT-101)…
The ability of the investigational drug crenolanib to inhibit a signaling molecule called PDGF reduced fibrosis in the skin and heart of…
Researchers from the Stanford University School of Medicine have identified a key element that is responsible for fibrosis of many incurable…
A rare condition of scleroderma, known as keloidal or nodular scleroderma, characterized by the presence of rigid and well-defined nodules…
A recent study reported that long-term treatment with Tracleer (bosentan) can be beneficial for patients with systemic sclerosis by reducing…